Feedback / Questions
Cvac (cancer vaccine MUC-1) - Immutep, Sydys Corp
Conference Call
(Immutep)
-
Dec 7, 2012 -
"Promising trend in PFS data; Median PFS (as of Aug 2012), NR Cvac: 421 D, Cvac: 365 D, Control: 321 D"
P2 data
•
Ovarian Cancer
http://www.larvolonline.com/tlg/ccdb/PrimaBiomedConferenceCallNov142012.pdf
Dec 7, 2012
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.